# Novo Nordisk CEO addresses Ozempic pricing in Washington – Novo Nordisk CEO, Lars Fruergaard Jorgensen, recently testified in Washington regarding the pricing of the popular diabetes drug, Ozempic. – The CEO highlighted the company’s commitment to making Ozempic accessible to patients by offering patient assistance programs to ease the financial burden. – Jorgensen emphasized the importance of innovation in the pharmaceutical industry to drive progress and improve patient outcomes. ### Hot take: It’s evident that Novo Nordisk is dedicated to providing affordable options for patients in need of Ozempic to manage their diabetes effectively. By offering patient assistance programs and emphasizing the value of innovation, the company is taking steps to address concerns about drug pricing and accessibility. **Contact Mindful Evolution for expert guidance and support on your weight loss journey. We offer telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Visit our website at https://yourmindfulevolution.com or call/text us at 954-639-9960.**